z-logo
open-access-imgOpen Access
β-Hydroxybutyrate Mitigated Heart Failure with Preserved Ejection Fraction by Increasing Treg Cells via Nox2/GSK-3β
Author(s) -
Shengen Liao,
Yuan Tang,
Xin Yue,
Rongrong Gao,
Wenming Yao,
Yanli Zhou,
Haifeng Zhang
Publication year - 2021
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s331320
Subject(s) - ejection fraction , heart failure , cardiac function curve , inflammation , medicine , nadph oxidase , myocardial fibrosis , fibrosis , cardiac fibrosis , downregulation and upregulation , endocrinology , ventricular remodeling , oxidative stress , chemistry , biochemistry , gene
This study was designed to investigate the cardioprotective role of β-hydroxybutyrate (BHB) in heart failure with preserved ejection fraction (HFpEF) and the underlying mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here